Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
The Vita Coco Company, Inc. files its annual report describing a coconut-water focused beverage business built on an asset-light global supply chain and two segments: Americas and International. Coconut water accounts for 96% of revenue for the year ended December 31, 2025, making category health and brand strength critical.
The company highlights leadership of its Vita Coco brand in U.S. and U.K. coconut water, expansion into Private Label and PWR LIFT, and reliance on contract manufacturers and Tetra Pak packaging. It outlines extensive risk factors, including supply chain disruptions, raw material and freight cost volatility, customer concentration, intense competition, climate change, regulatory compliance, and obligations tied to its public benefit corporation and Certified B Corporation status.
The Vita Coco Company reported strong fourth quarter and full year 2025 results, with full year net sales of $610 million, up 18%, driven by 26% growth in Vita Coco Coconut Water. Full year net income rose to $71 million from $56 million, and diluted EPS increased to $1.19 from $0.94.
Non-GAAP Adjusted EBITDA grew to $98 million from $84 million, supported by higher pricing and volume, despite tariff and cost pressures. The company ended 2025 with no debt, cash and cash equivalents of $197 million, and executed $11.3 million of share repurchases, leaving $40.9 million authorized.
For fiscal 2026, Vita Coco expects net sales between $680 million and $700 million, gross margin of about 38%, and Adjusted EBITDA between $122 million and $128 million, reflecting continued growth in Vita Coco Coconut Water and improving Private Label trends.
Verlinvest Beverages SA, a Belgian company, reports beneficial ownership of 3,097,161 shares of common stock of The Vita Coco Company, Inc.. This represents 5.4% of the company’s common stock, based on 56,948,258 shares outstanding as of October 27, 2025.
Verlinvest reports sole voting and dispositive power over all of these shares, with no shared voting or investment authority and no group arrangements disclosed. The filing is an amendment to a prior ownership report, confirming Verlinvest as a significant but non-controlling shareholder.
Vita Coco Company, Inc. director Ira Liran reported planned stock sales under a Rule 10b5-1 trading plan. On February 5, 2026, he sold 20,000 shares of common stock directly at a weighted average price of $56.66, leaving 478,341 shares held directly.
On the same date, an additional 30,000 shares of common stock were sold indirectly at a weighted average price of $56.65, with 572,579 shares held indirectly by the Ira Liran 2012 Family Trust. Both reported prices reflect multiple trades within stated intraday price ranges.
Vita Coco Co Inc received an updated ownership report from FMR LLC and Abigail P. Johnson12/31/2025. The filing shows beneficial ownership of 5,152,157.52 shares of common stock, representing 9.0% of the outstanding class.
FMR LLC has sole voting power over 5,147,925 shares and sole dispositive power over 5,152,157.52 shares. Abigail P. Johnson reports sole dispositive power over the same 5,152,157.52 shares, with no voting power. The securities are held in the ordinary course of business and not for the purpose of changing or influencing control. One or more other persons may receive dividends or sale proceeds, but no such person holds more than 5% of the class.
Vita Coco Company, Inc. director Kenneth Sadowsky reported selling 3,900 shares of common stock on January 21, 2026 at a weighted average price of $53.92 per share. The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan, meaning the trades were scheduled in advance.
After this transaction, Sadowsky beneficially owned 608,266 shares of Vita Coco common stock in direct ownership. He also holds a non-qualified stock option to buy 27,300 shares of common stock at an exercise price of $10.178 per share, which is fully vested and currently exercisable and expires on January 2, 2030.
Vita Coco Company, Inc. director Shelley G. Broader reported an equity award of 520 shares of common stock in the form of restricted stock units (RSUs) on 01/07/2026. The RSUs were granted at a price of $0.00 per share under the company’s 2021 Incentive Award Plan.
The 520 RSUs vest in full on the earlier of the day immediately preceding the next annual stockholders meeting after the grant date or the first anniversary of the grant date, as long as Broader remains in continuous service through the applicable vesting date. Following this grant, Broader beneficially owns 520 common shares directly.
Vita Coco Company, Inc. director Shelley G. Broader filed an initial insider ownership report on Form 3 in connection with the company’s stock (ticker COCO) as of 01/07/2026. The filing states that no securities of Vita Coco, including common stock or derivative securities, are beneficially owned.
The Vita Coco Company reported board and leadership changes. On January 7, 2026, the Board of Directors increased its size from nine to ten members and appointed Shelley Broader as a Class II director, serving until the end of Class II’s term at the next annual meeting of stockholders and until a successor is elected and qualified. She will receive the standard non-employee director compensation and is expected to be named to one or more board committees later.
The company stated that Ms. Broader has no arrangements related to her appointment and no material related-party transactions requiring disclosure. On January 7, 2026, the Board also appointed Charles van Es as Chief Commercial Officer, effective January 1, 2026, to lead global commercial strategy and market development while continuing to oversee the U.S. market, with no changes to his compensation.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported a charitable stock donation and his current equity holdings. On December 18, 2025, he donated 666 shares of Vita Coco common stock to a donor-advised fund for charitable purposes, leaving him with 73,847 common shares held directly.
He also reported multiple non-qualified stock options to buy Vita Coco common stock at exercise prices ranging from $10.178 to $33.36, with expiration dates between December 16, 2029 and March 4, 2035. Several of these options are fully vested and currently exercisable, while others vest in equal annual installments beginning on dates from November 27, 2022 through future grant anniversaries, contingent on continued service.